Navigation Links
CardiacAssist, Inc. Surpasses 1300 TandemHeart System Procedures
Date:6/19/2008

Circulatory assist device's high net flow rate supports a multitude of

highly complex procedures in life threatening situations

PITTSBURGH, June 19 /PRNewswire/ -- CardiacAssist, Inc., a Pittsburgh- based medical device company that develops, manufacturers and markets cardiac assist devices, has announced the completion of the 1300th worldwide procedure utilizing the TandemHeart System. This is indicative of TandemHeart's increasing acceptance and use by cardiologists and surgeons. The TandemHeart System is unique in helping heart failure patients survive both heart attacks and high risk procedures, while providing versatility to physicians in choosing the time, place and type of treatments.

The TandemHeart System is now used in over 100 heart centers across the U.S. Ten prestigious heart centers were recently active in helping CardiacAssist, Inc. surpass the 1300th procedure for its TandemHeart System. These ten heart centers include:

-- Brigham & Women's Hospital in Boston, MA

-- Cleveland Clinic in Cleveland, OH

-- Hospital of the University of Pennsylvania in Philadelphia, PA.

-- Lahey Clinic in Burlington, MA

-- Lenox Hill in New York City, NY

-- Mayo Clinic in Rochester, MN

-- Mt. Sinai in New York City, NY

-- Sacred Heart Medical Center in Spokane, WA

-- St. Luke's Hospital in Kansas City, MO

-- Texas Heart Institute in Houston, TX

In each situation the TandemHeart System was selected for its high net flow rate of up to 5 lpm in the Cath Lab or up to 8 lpm in the OR as well as its flexibility and rapid deployment potential. There are a variety of FDA cleared devices that provide extracorporeal circulatory support, but all others offer less than half the net flow and hemodynamic support of the TandemHeart System.

The TandemHeart System is the only 5 lpm net flow, percutaneous "extracorporeal circulatory support" device approved by the FDA for sale in the U.S. Other devices including Impella 2.5 are labeled by the FDA to be used for "partial circulatory support" with less than 2.5 lpm net flow.

The TandemHeart System is fully reimbursed by Medicare under existing DRG codes. The device can be placed rapidly in the cath lab or operating room, providing effective, reliable, temporary circulatory support for critically ill patients.

Contact:

Pamela McDonald

Marketing Assistant

Ph: 412-963-7770 ext. 226

pmcdonald@cardiacassist.com


'/>"/>
SOURCE CardiacAssist, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System
2. NanoInterventions Launches New, Rapid Testing System for Coronary Stents
3. Ahram Biosystems Completes Development of a Palm-Size Portable PCR Device
4. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
5. Cardiac Science Launches Anywhere Data Management for HIS and EMR Systems
6. Coapt Systems New CEO, Laureen DeBuono, to Fuel Companys Growth and Product Innovation
7. PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress
8. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
9. Stem Cell Researcher Wins Award for Excellence for Work With the ImageStream(R) System
10. WellCentive Launches New Secure Messaging Platform for Its Patient Registry System
11. Environmental Tectonics Corporations BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
Breaking Biology Technology:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
Breaking Biology News(10 mins):